SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)

计划入组 86 人 · 首次发布于 2019 年 1 月 16 日

Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH)

计划入组 40 人 · 首次发布于 2015 年 8 月 13 日

Controlled Human Malaria Infection in Semi-Immune Kenyan Adults. (CHMI-SIKA)

计划入组 200 人 · 首次发布于 2016 年 4 月 15 日

SIK Inhibitor (Nimbus Therapeutics)

SIK inhibitor (immunological disease)

SIK inhibitor therapy(Nimbus Therapeutics)

SIKKIM MANIPAL UNIVERSITY

India

ADENTA SIA

Latvia

Water Pik, Inc.

United States

Nimbus Therapeutics Advances Novel SIK2 Inhibitors for Inflammatory Bowel Disease with Dual Anti-Inflammatory and Mucosal Healing Mechanism

Onco3R Therapeutics Receives Regulatory Approval for First-in-Human Trial of Novel SIK3 Inhibitor O3R-5671

Onco3R Therapeutics Reports Positive Phase 1 Data for Novel SIK3 Inhibitor O3R-5671 in Autoimmune Disease Treatment